![Michael Shetzline](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Shetzline
Direktor/Vorstandsmitglied bei
PharmaIN Corp.
Vermögen: 3 Mio $ am 31.07.2026
Profil
Michael Shetzline is currently Director at PharmaIN Corp.
Former positions include Chief Medical Officer & Senior Vice President at Ironwood Pharmaceuticals, Inc. from 2019 to 2026, VP & Head-Gastroenterology Clinical Sciences at Takeda Pharmaceuticals International, Inc. from 2015 to 2019, VP & Global Head-Gastroenterology at Ferring International Pharmascience Center US, Inc. from 2012 to 2015, Vice President at Novartis Pharmaceuticals AG from 2002 to 2012, and Director-Gastroenterology Program at Duke University Medical Center from 1997 to 2002.
Education includes a doctorate from The Ohio State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.03.2026 | 658’037 ( 0.4% ) | 3 Mio $ | 31.07.2026 |
Aktive Positionen von Michael Shetzline
| Unternehmen | Position | Beginn |
|---|---|---|
PharmaIN Corp.
 PharmaIN Corp. Pharmaceuticals: MajorHealth Technology Develops affinity-based drug delivery solutions for biotech and pharmaceutical applications | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Michael Shetzline
| Unternehmen | Position | Ende |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 20.07.2026 |
Takeda Pharmaceuticals International, Inc.
 Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting for pharmaceutical businesses | Corporate Officer/Principal | 01.01.2019 |
Ferring International Pharmascience Center US, Inc.
 Ferring International Pharmascience Center US, Inc. BiotechnologyHealth Technology Develops pharmaceutical drugs | Corporate Officer/Principal | 01.01.2015 |
Novartis Pharmaceuticals AG | Corporate Officer/Principal | 01.01.2012 |
Duke University Medical Center
 Duke University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2002 |
Ausbildung von Michael Shetzline
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
65
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
PharmaIN Corp.
PharmaIN Corp. Pharmaceuticals: MajorHealth Technology Develops affinity-based drug delivery solutions for biotech and pharmaceutical applications | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University Medical Center
Duke University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceuticals International, Inc.
Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting for pharmaceutical businesses | Commercial Services |
Novartis Pharmaceuticals AG | |
Ferring International Pharmascience Center US, Inc.
Ferring International Pharmascience Center US, Inc. BiotechnologyHealth Technology Develops pharmaceutical drugs | Health Technology |
